Difficulty: Medium
Average Score: 63%
Practice
This drug has activity against many strains of Pseudomonas aeruginosa. However, when it is used alone, resistance has emerged during the course of treatment. The drug should not be used in penicillin-allergic patients. Its activity against gram-negative rods is enhanced if it is given in combination with tazobactam
Correct answer
D
Rationale
The correct answer is D) Piperacillin. Piperacillin is a broad-spectrum antibiotic with activity against many strains of Pseudomonas aeruginosa. However, when used alone, resistance can develop during treatment. Piperacillin is not recommended for penicillin-allergic patients due to its structural similarity to penicillin. When combined with tazobactam, an inhibitor of beta-lactamase enzymes, piperacillin's activity against gram-negative rods, including Pseudomonas aeruginosa, is enhanced.
A) Amoxicillin is a penicillin-class antibiotic and is not effective against Pseudomonas aeruginosa.
B) Aztreonam is a monobactam antibiotic that is effective against Pseudomonas aeruginosa but does not require combination with tazobactam for enhanced activity against gram-negative rods.
C) Imipenem is a carbapenem antibiotic with broad-spectrum activity, but it is not the best choice for Pseudomonas aeruginosa and does not require combination with tazobactam for efficacy.
Educationally, understanding the spectrum of activity, mechanisms of resistance, and appropriate combinations of antibiotics is crucial for effective clinical decision-making in the treatment of infections. This question highlights the importance of selecting the right antibiotic and combination therapy to optimize treatment outcomes and prevent the development of resistance.
A) Amoxicillin is a penicillin-class antibiotic and is not effective against Pseudomonas aeruginosa.
B) Aztreonam is a monobactam antibiotic that is effective against Pseudomonas aeruginosa but does not require combination with tazobactam for enhanced activity against gram-negative rods.
C) Imipenem is a carbapenem antibiotic with broad-spectrum activity, but it is not the best choice for Pseudomonas aeruginosa and does not require combination with tazobactam for efficacy.
Educationally, understanding the spectrum of activity, mechanisms of resistance, and appropriate combinations of antibiotics is crucial for effective clinical decision-making in the treatment of infections. This question highlights the importance of selecting the right antibiotic and combination therapy to optimize treatment outcomes and prevent the development of resistance.